禁食减轻肠道放射毒性,使胰腺癌放疗剂量提升成为可能
该研究在C57BL/6J小鼠中比较24小时禁食与自由进食后接受11.5 Gy全腹部照射的效应,发现禁食改善肠道干细胞再生和宿主生存,且不影响肿瘤细胞杀伤,甚至增强γ-H2AX染色提示轻度放射增敏。结果支持禁食作为剂量提升策略实现胰腺癌消融放疗的概念验证。
要点
- 24小时禁食改善小鼠全腹部照射后肠道干细胞再生与宿主生存。
- 禁食不影响放疗对胰腺肿瘤细胞的杀伤,并可能增强γ-H2AX提示放射增敏。
- 禁食作为剂量提升策略实现不可切除胰腺癌消融放疗的概念验证。
核心结论
- 禁食可减轻肠道放射毒性并支持胰腺癌放疗剂量提升至消融水平的概念验证。
研究设计与样本
- C57BL/6J小鼠禁食或进食24小时后接受11.5 Gy全腹部照射,监测摄食、体重、健康与生存。
- 照射后不同时间点取小肠评估绒毛长度、隐窝深度及每毫米隐窝数,并行免疫组化检测凋亡与双链DNA断裂,微集落实验评估肠道干细胞再生能力。
- 采用同源KPC胰腺癌模型评估禁食对胰腺癌与宿主肠道组织放疗反应的影响。
主要发现
- 24小时禁食小鼠经微集落实验显示肠道干细胞再生改善,并提高致死剂量全腹部照射后的宿主生存。
- 禁食改善接受致死性腹部照射的原位胰腺肿瘤小鼠生存。
- 禁食不影响放疗对肿瘤细胞的杀伤,并增强放疗后γ-H2AX染色,提示额外轻度放射增敏效应。
临床怎么用
- 结果提示禁食可能作为剂量提升策略,使不可切除胰腺癌实现消融放疗。
局限性
- 证据来自小鼠模型,尚未在人体验证禁食的安全性与有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Chemotherapy combined with radiation therapy is the most commonly used approach for treating locally advanced pancreatic cancer. The use of curative doses of radiation in this disease setting is constrained because of the close proximity of the head of the pancreas to the duodenum. The purpose of this study was to determine whether fasting protects the duodenum from high-dose radiation, thereby enabling dose escalation for efficient killing of pancreatic tumor cells. METHODS AND MATERIALS: C57BL/6J mice were either fed or fasted for 24 hours and then exposed to total abdominal radiation at 11.5 Gy. Food intake, body weight, overall health, and survival were monitored. Small intestines were harvested at various time points after radiation, and villi length, crypt depth, and number of crypts per millimeter of intestine were determined. Immunohistochemistry was performed to assess apoptosis and double-strand DNA breaks, and microcolony assays were performed to determine intestinal stem cell regeneration capacity. A syngeneic KPC model of pancreatic cancer was used to determine the effects of fasting on the radiation responses of both pancreatic cancer and host intestinal tissues. RESULTS: We demonstrated that a 24-hour fast in mice improved intestinal stem cell regeneration, as revealed by microcolony assay, and improved host survival of lethal doses of total abdominal irradiation compared with fed controls. Fasting also improved survival of mice with orthotopic pancreatic tumors subjected to lethal abdominal radiation compared with controls with free access to food. Furthermore, fasting did not affect tumor cell killing by radiation therapy and enhanced γ-H2AX staining after radiation therapy, suggesting an additional mild radiosensitizing effect. CONCLUSIONS: These results establish proof of concept for fasting as a dose-escalation strategy, enabling ablative radiation in the treatment of unresectable pancreatic cancer.
引用
- de la Cruz Bonilla M, Stemler KM, Jeter-Jones S, et al. Fasting Reduces Intestinal Radiotoxicity, Enabling Dose-Escalated Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 31271824. doi:10.1016/j.ijrobp.2019.06.2533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。